The University of Manchester is a founding partner of the Kenya-UK Healthcare Alliance, which aims to share best practice and reciprocal training between the two nations, particularly in the area of cancer care. In this article, from our On Cancer publication, Professor Keith Brennan, Dr F. George Njoroge, and Professor Rob Bristow outline how these […]
Fighting the war with drugs: How can psychedelic-assisted therapies help veterans?
Around 17% of recent military veterans in the UK report symptoms of post-traumatic stress disorder (PTSD) and currently available treatments don’t work for many of these. Here, Professor Jo Neill, Dr Verity Wainwright, and Frances Smith report the findings of a new study into the role that psilocybin (the active constituent of so-called ‘magic’ mushrooms) […]
Advancing cell and gene therapies: Levelling-up life sciences investment in the North-West
Life sciences – including new cancer treatments – forms a central pillar of the UK Government’s post-Brexit plan for science and technology. But how could this focus also play a role in another key tenet of British policymaking; the levelling-up agenda? In this blog, adapted from our On Cancer publication, Professor Fiona Thistlethwaite and Professor […]
The role of R&D in the levelling up agenda
Innovation drives productivity, and R&D importantly underpins innovation. Places in the south-east of the UK disproportionately hold the highest rates of public and charitable spending on R&D. In order to mend the geographical imbalances in R&D spending, the way that funding is allocated must be changed. This can be challenging given the patchy nature of […]